Home Healthcare Pharmaceuticals Melanoma Therapeutics Market

Melanoma Therapeutics Market Size, Share & Trends Analysis Report By Type (Superficial Spreading Melanoma, Nodular Melanoma, Lentigno Maligna Melanoma, Acral Lentiginous Melanoma, Amelanotic Melanoma, Others), By Treatment (Chemotherapy, Biological Therapy, Radiotherapy, Targeted Therapy, Immunotherapy, Surgery), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: July 30, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Melanoma Therapeutics Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Superficial Spreading Melanoma
    2. Nodular Melanoma
    3. Lentigno Maligna Melanoma
    4. Acral Lentiginous Melanoma
    5. Amelanotic Melanoma
    6. Others
  2. Melanoma Therapeutics Market, By Treatment 2022-2034 (USD MILLION/ Units)
    1. Chemotherapy
    2. Biological Therapy
    3. Radiotherapy
    4. Targeted Therapy
    5. Immunotherapy
    6. Surgery
  3. Melanoma Therapeutics Market, By Distribution Channel 2022-2034 (USD MILLION/ Units)
    1. Hospital Pharmacy
    2. Online Pharmacy
    3. Retail Pharmacy
  4. Regional Melanoma Therapeutics Market
    1. North America
      1. North America Melanoma Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
      2. North America Melanoma Therapeutics Market By Treatment 2022-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Biological Therapy
        3. Radiotherapy
        4. Targeted Therapy
        5. Immunotherapy
        6. Surgery
      3. North America Melanoma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Online Pharmacy
        3. Retail Pharmacy
      4. U.S.
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
        7. Chemotherapy
        8. Biological Therapy
        9. Radiotherapy
        10. Targeted Therapy
        11. Immunotherapy
        12. Surgery
        13. Hospital Pharmacy
        14. Online Pharmacy
        15. Retail Pharmacy
      5. Canada
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
        7. Chemotherapy
        8. Biological Therapy
        9. Radiotherapy
        10. Targeted Therapy
        11. Immunotherapy
        12. Surgery
        13. Hospital Pharmacy
        14. Online Pharmacy
        15. Retail Pharmacy
    2. Europe
      1. Europe Melanoma Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
      2. Europe Melanoma Therapeutics Market By Treatment 2022-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Biological Therapy
        3. Radiotherapy
        4. Targeted Therapy
        5. Immunotherapy
        6. Surgery
      3. Europe Melanoma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Online Pharmacy
        3. Retail Pharmacy
      4. U.K.
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
        7. Chemotherapy
        8. Biological Therapy
        9. Radiotherapy
        10. Targeted Therapy
        11. Immunotherapy
        12. Surgery
        13. Hospital Pharmacy
        14. Online Pharmacy
        15. Retail Pharmacy
      5. Germany
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
        7. Chemotherapy
        8. Biological Therapy
        9. Radiotherapy
        10. Targeted Therapy
        11. Immunotherapy
        12. Surgery
        13. Hospital Pharmacy
        14. Online Pharmacy
        15. Retail Pharmacy
      6. France
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
        7. Chemotherapy
        8. Biological Therapy
        9. Radiotherapy
        10. Targeted Therapy
        11. Immunotherapy
        12. Surgery
        13. Hospital Pharmacy
        14. Online Pharmacy
        15. Retail Pharmacy
      7. Spain
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
        7. Chemotherapy
        8. Biological Therapy
        9. Radiotherapy
        10. Targeted Therapy
        11. Immunotherapy
        12. Surgery
        13. Hospital Pharmacy
        14. Online Pharmacy
        15. Retail Pharmacy
      8. Italy
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
        7. Chemotherapy
        8. Biological Therapy
        9. Radiotherapy
        10. Targeted Therapy
        11. Immunotherapy
        12. Surgery
        13. Hospital Pharmacy
        14. Online Pharmacy
        15. Retail Pharmacy
      9. Russia
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
        7. Chemotherapy
        8. Biological Therapy
        9. Radiotherapy
        10. Targeted Therapy
        11. Immunotherapy
        12. Surgery
        13. Hospital Pharmacy
        14. Online Pharmacy
        15. Retail Pharmacy
      10. Nordic
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
        7. Chemotherapy
        8. Biological Therapy
        9. Radiotherapy
        10. Targeted Therapy
        11. Immunotherapy
        12. Surgery
        13. Hospital Pharmacy
        14. Online Pharmacy
        15. Retail Pharmacy
      11. Benelux
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
        7. Chemotherapy
        8. Biological Therapy
        9. Radiotherapy
        10. Targeted Therapy
        11. Immunotherapy
        12. Surgery
        13. Hospital Pharmacy
        14. Online Pharmacy
        15. Retail Pharmacy
      12. Rest of Europe
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
        7. Chemotherapy
        8. Biological Therapy
        9. Radiotherapy
        10. Targeted Therapy
        11. Immunotherapy
        12. Surgery
        13. Hospital Pharmacy
        14. Online Pharmacy
        15. Retail Pharmacy
    3. APAC
      1. APAC Melanoma Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
      2. APAC Melanoma Therapeutics Market By Treatment 2022-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Biological Therapy
        3. Radiotherapy
        4. Targeted Therapy
        5. Immunotherapy
        6. Surgery
      3. APAC Melanoma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Online Pharmacy
        3. Retail Pharmacy
      4. China
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
        7. Chemotherapy
        8. Biological Therapy
        9. Radiotherapy
        10. Targeted Therapy
        11. Immunotherapy
        12. Surgery
        13. Hospital Pharmacy
        14. Online Pharmacy
        15. Retail Pharmacy
      5. Korea
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
        7. Chemotherapy
        8. Biological Therapy
        9. Radiotherapy
        10. Targeted Therapy
        11. Immunotherapy
        12. Surgery
        13. Hospital Pharmacy
        14. Online Pharmacy
        15. Retail Pharmacy
      6. Japan
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
        7. Chemotherapy
        8. Biological Therapy
        9. Radiotherapy
        10. Targeted Therapy
        11. Immunotherapy
        12. Surgery
        13. Hospital Pharmacy
        14. Online Pharmacy
        15. Retail Pharmacy
      7. India
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
        7. Chemotherapy
        8. Biological Therapy
        9. Radiotherapy
        10. Targeted Therapy
        11. Immunotherapy
        12. Surgery
        13. Hospital Pharmacy
        14. Online Pharmacy
        15. Retail Pharmacy
      8. Australia
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
        7. Chemotherapy
        8. Biological Therapy
        9. Radiotherapy
        10. Targeted Therapy
        11. Immunotherapy
        12. Surgery
        13. Hospital Pharmacy
        14. Online Pharmacy
        15. Retail Pharmacy
      9. Taiwan
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
        7. Chemotherapy
        8. Biological Therapy
        9. Radiotherapy
        10. Targeted Therapy
        11. Immunotherapy
        12. Surgery
        13. Hospital Pharmacy
        14. Online Pharmacy
        15. Retail Pharmacy
      10. South East Asia
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
        7. Chemotherapy
        8. Biological Therapy
        9. Radiotherapy
        10. Targeted Therapy
        11. Immunotherapy
        12. Surgery
        13. Hospital Pharmacy
        14. Online Pharmacy
        15. Retail Pharmacy
      11. Rest of Asia-Pacific
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
        7. Chemotherapy
        8. Biological Therapy
        9. Radiotherapy
        10. Targeted Therapy
        11. Immunotherapy
        12. Surgery
        13. Hospital Pharmacy
        14. Online Pharmacy
        15. Retail Pharmacy
    4. Middle East and Africa
      1. Middle East and Africa Melanoma Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
      2. Middle East and Africa Melanoma Therapeutics Market By Treatment 2022-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Biological Therapy
        3. Radiotherapy
        4. Targeted Therapy
        5. Immunotherapy
        6. Surgery
      3. Middle East and Africa Melanoma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Online Pharmacy
        3. Retail Pharmacy
      4. UAE
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
        7. Chemotherapy
        8. Biological Therapy
        9. Radiotherapy
        10. Targeted Therapy
        11. Immunotherapy
        12. Surgery
        13. Hospital Pharmacy
        14. Online Pharmacy
        15. Retail Pharmacy
      5. Turkey
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
        7. Chemotherapy
        8. Biological Therapy
        9. Radiotherapy
        10. Targeted Therapy
        11. Immunotherapy
        12. Surgery
        13. Hospital Pharmacy
        14. Online Pharmacy
        15. Retail Pharmacy
      6. Saudi Arabia
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
        7. Chemotherapy
        8. Biological Therapy
        9. Radiotherapy
        10. Targeted Therapy
        11. Immunotherapy
        12. Surgery
        13. Hospital Pharmacy
        14. Online Pharmacy
        15. Retail Pharmacy
      7. South Africa
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
        7. Chemotherapy
        8. Biological Therapy
        9. Radiotherapy
        10. Targeted Therapy
        11. Immunotherapy
        12. Surgery
        13. Hospital Pharmacy
        14. Online Pharmacy
        15. Retail Pharmacy
      8. Egypt
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
        7. Chemotherapy
        8. Biological Therapy
        9. Radiotherapy
        10. Targeted Therapy
        11. Immunotherapy
        12. Surgery
        13. Hospital Pharmacy
        14. Online Pharmacy
        15. Retail Pharmacy
      9. Nigeria
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
        7. Chemotherapy
        8. Biological Therapy
        9. Radiotherapy
        10. Targeted Therapy
        11. Immunotherapy
        12. Surgery
        13. Hospital Pharmacy
        14. Online Pharmacy
        15. Retail Pharmacy
      10. Rest of MEA
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
        7. Chemotherapy
        8. Biological Therapy
        9. Radiotherapy
        10. Targeted Therapy
        11. Immunotherapy
        12. Surgery
        13. Hospital Pharmacy
        14. Online Pharmacy
        15. Retail Pharmacy
    5. LATAM
      1. LATAM Melanoma Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
      2. LATAM Melanoma Therapeutics Market By Treatment 2022-2034 (USD MILLION/ Units)
        1. Chemotherapy
        2. Biological Therapy
        3. Radiotherapy
        4. Targeted Therapy
        5. Immunotherapy
        6. Surgery
      3. LATAM Melanoma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Online Pharmacy
        3. Retail Pharmacy
      4. Brazil
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
        7. Chemotherapy
        8. Biological Therapy
        9. Radiotherapy
        10. Targeted Therapy
        11. Immunotherapy
        12. Surgery
        13. Hospital Pharmacy
        14. Online Pharmacy
        15. Retail Pharmacy
      5. Mexico
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
        7. Chemotherapy
        8. Biological Therapy
        9. Radiotherapy
        10. Targeted Therapy
        11. Immunotherapy
        12. Surgery
        13. Hospital Pharmacy
        14. Online Pharmacy
        15. Retail Pharmacy
      6. Argentina
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
        7. Chemotherapy
        8. Biological Therapy
        9. Radiotherapy
        10. Targeted Therapy
        11. Immunotherapy
        12. Surgery
        13. Hospital Pharmacy
        14. Online Pharmacy
        15. Retail Pharmacy
      7. Chile
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
        7. Chemotherapy
        8. Biological Therapy
        9. Radiotherapy
        10. Targeted Therapy
        11. Immunotherapy
        12. Surgery
        13. Hospital Pharmacy
        14. Online Pharmacy
        15. Retail Pharmacy
      8. Colombia
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
        7. Chemotherapy
        8. Biological Therapy
        9. Radiotherapy
        10. Targeted Therapy
        11. Immunotherapy
        12. Surgery
        13. Hospital Pharmacy
        14. Online Pharmacy
        15. Retail Pharmacy
      9. Rest of LATAM
        1. Superficial Spreading Melanoma
        2. Nodular Melanoma
        3. Lentigno Maligna Melanoma
        4. Acral Lentiginous Melanoma
        5. Amelanotic Melanoma
        6. Others
        7. Chemotherapy
        8. Biological Therapy
        9. Radiotherapy
        10. Targeted Therapy
        11. Immunotherapy
        12. Surgery
        13. Hospital Pharmacy
        14. Online Pharmacy
        15. Retail Pharmacy
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.